Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(30 sites)

United States

The University of Alabama at Birmingham Hospital, Birmingham, Alabama

Moffitt Cancer Center, Tampa, Florida

Baptist Health Hardin, Elizabethtown, Kentucky

NYU Langone - NYU Grossman School of Medicine, New York, New York

Texas Oncology, P.A., Houston, Texas

Australia

Liverpool Cancer Therapy Centre, Liverpool, New South Wales

Metro South Health - Princess Alexandra Hospital (PAH), Woolloongabba, Queensland

Cancer Research SA (CRSA), Adelaide, South Austraila

Hobart Hospital-Royal Hobart Hospital, Hobart, Tasmania

One Clinical Research - Hollywood Private Hospital, Nedlands, Western Australia

South Korea

Gyeongsang National University Hospital (GNUH), Jinju, Gyeongsangnam-do

Chungbuk National University Hospital, Cheongju-si

Gachon University Gil Medical Center, Incheon

Severance Hospital, Yonsei University Health System, Seoul

Samsung Medical Center, Seoul

Spain

Institut dInvestigacio Biomedica de Bellvitge (IDIBELL), Barcelona

Hospital Universitario Ramón y Cajal, Madrid

Hospital Universitario Fundacion Jimenez Diaz, Madrid

Hospital Universitario Virgen del Rocio, Seville

Universitat de Valencia - Hospital Universitari i Politecnic La Fe de Valencia (Hospital La Fe Bulevar Sur), Valencia

Turkey (Türkiye)

Baskent University Adana Turgut Noyan Application and Research Center Kisla Health Campus, Adana

Memorial Ankara Hospital, Ankara

Ankara Bilkent City Hospital, Ankara

Memorial Antalya Hospital, Antalya

Yeditepe University Hospital, Istanbul

Koc Universitesi Hastanesi (Koc University Hospital), Zeytinburnu

United Kingdom

Velindre NHS Trust, Velindre Cancer Centre, Cardiff

St James's University Hospital - Leeds Teaching Hospitals NHS Trust, Leeds

Sarah Cannon Research Institute, London

The Christie NHS Foundation Trust, Manchester